Hidden by HIPAA: The costs of cure

Journal of Clinical Oncology

Volumn 23, Issue 16, 2005, Pages 3663-3665

  Raghavan, Derek ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN;

ADVERSE DRUG REACTION; ALLERGIC PNEUMONITIS; ALOPECIA; ANOREXIA; AUTONOMIC NEUROPATHY; BONE MARROW SUPPRESSION; CANCER THERAPY; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; DEPRESSION; DYSPLASTIC NEVUS; EDITORIAL; FIBROSIS; HEALTH INSURANCE; HEALTH PROGRAM; HEALTH SURVEY; HEARING LOSS; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOMAGNESEMIA; INFECTION; INFERTILITY; JOB PERFORMANCE; KIDNEY FAILURE; LEUKEMIA; LUNG TOXICITY; MARRIAGE; MEDICAL INFORMATION; MELANOMA; NAUSEA AND VOMITING; NEPHRITIS; NEPHROTOXICITY; OSTEOPOROSIS; PERIPHERAL NEUROPATHY; PERIPHERAL VASCULAR DISEASE; PNEUMONIA; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RISK ASSESSMENT; SIDE EFFECT; SOCIOPATHY; SOLID TUMOR; TESTIS CANCER; UREMIA; CONFIDENTIALITY; COST; HEALTH CARE COST; NOTE; UNITED STATES;

CONFIDENTIALITY; COSTS AND COST ANALYSIS; HEALTH CARE COSTS; HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT; HUMANS; UNITED STATES;

EID: 20544470157     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.11.951     Document Type: Editorial

References (18)

1. Horvath L, Boyer MJ: Acute toxicity of chemotherapy, in Raghavan D (ed), American Cancer Society Atlas of Clinical Oncology: Germ Cell Tumors. London, United Kingdom, BC Decker, Hamilton, Canada, 2003, pp 340-348
2. Nuver J, Smit AJ, Wolffenbuttel BH, et al: The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer. J Clin Oncol 23:10.1200/JCO.2005.02.176
3. Raghavan D, Cox K, Childs A, et al: Hypercholesterolemia after chemotherapy for testis cancer. J Clin Oncol 10:1386-1389, 1992
4. Boyer M, Raghavan D, Harris PJ, et al: Lack of late toxicity in patients treated with cisplatin-containing combination chemotherapy for metastatic testicular cancer. J Clin Oncol 8:21-26, 1990
5. Bokemeyer C, Berger CC, Kuczyk MA, et al: Evaluation of long-term toxicity after chemotherapy for testicular cancer. J Clin Oncol 14:2923-2932, 1996
6. Nord C, Fossa SD, Egeland T: Excessive annual BMI increase after chemotherapy among young survivors of testicular cancer. Br J Cancer 88:36-41, 2003
7. Gietema JA, Meinardi MT, van der Graaf WT, et al: Syndrome X in testicular cancer survivors. Lancet 357:228-229, 2001
8. Meinardi MT, Gietema JA, van der Graaf WT, et al: Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol 18:1725-1732, 2000
9. Huddart RA, Norman A, Shahidi M, et al: Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol 21:1513-1523, 2003
10. Bosl GJ, Leitner SP, Atlas SA, et al: Increased plasma renin and aldosterone in patients treated with cisplatin-based chemotherapy for metastatic germ-cell tumors. J Clin Oncol 4:1684-1689, 1986
11. Pedersen-Bjergaard J, Daugaard G, Hansen SW, et al: Increased risk of myelodysplasia and leukemia after etoposide, cisplatin and bleomycin for germ-cell tumours. Lancet 338:359-363, 1991
12. Van Leeuwen FE, Stiggelbout AM, van den Belt-Dusebout A, et al: Second cancer risk following testicular cancer: A follow-up study of 1909 patients. J Clin Oncol 11:415-424, 1993
13. Segelov E, Raghavan D, Coates A, et al: Acute leukemia following chemotherapy including etoposide for testicular carcinoma. Aust N Z J Med 23:718-719, 1993
14. Travis LB, Curtis RE, Storm H, et al: Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst 89:1429-1439, 1997
15. Boyer MJ, Roth BJ: Toxicity of treatment of germ cell tumors, in Raghavan D, Scher HI, Leibel S, et al (eds): Principles and Practice of Genitourinary Oncology. Philadelphia, PA, Lippincott, 1997, pp 754-764
16. Kaldor JM, Day NE, Band P, et al: Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: An international collaborative study among cancer registries. Int J Cancer 39:571-585, 1987
17. Raghavan D, Zalcberg J, Grygiel JJ, et al: Multiple atypical nevi: A cutaneous marker of germ cell tumors. J Clin Oncol 12:2284-2287, 1994
18. Raghavan D: Follow up of the patient with testicular cancer, in Johnson FS, Virgo K (eds): Cancer Patient Follow Up. St Louis, MO, Mosby-Year Book, 1995